Literature DB >> 27926971

Management of Endometriomas.

Ludovico Muzii1, Chiara Di Tucci1, Mara Di Feliciantonio1, Giulia Galati1, Ludovica Verrelli1, Violante Di Donato1, Claudia Marchetti1, Pierluigi Benedetti Panici1.   

Abstract

Ovarian endometriomas affect 17 to 44% of women with endometriosis, and are often associated with pelvic pain and infertility. Treatment options include expectant management, medical and/or surgical treatment, and in vitro fertilization and embryo transfer (IVF-ET). The choice of treatment depends mostly on the associated symptoms. In most cases, surgery is the preferred choice, since endometriomas do not respond to medical treatment, which may only treat associated pain. In case of infertility, IVF-ET may be a suitable alternative to surgery, particularly when there is no associated pain. According to the best available scientific evidence, laparoscopic excision of the endometrioma wall should be considered the procedure of choice. Concerns have been raised as to the possibility that surgical excision may damage the ovarian reserve, but recent evidences demonstrate that part of the damage may be due to the presence of the endometrioma itself. Indication to surgical treatment should balance the possible risks of damaging the ovarian reserve with the advantages of surgery in terms of satisfactory pain relief rates and pregnancy rates, and of obtaining tissue specimen for ruling out the rare cases of unexpected ovarian malignancy. A score system to guide the clinician in the decision to perform or withhold surgery is presented. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27926971     DOI: 10.1055/s-0036-1597126

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  5 in total

Review 1.  Endometrioma and assisted reproductive technology: a review.

Authors:  Mira H Kheil; Fady I Sharara; Jean Marc Ayoubi; Sara Rahman; Gaby Moawad
Journal:  J Assist Reprod Genet       Date:  2022-01-24       Impact factor: 3.412

Review 2.  Risk factors for ovarian endometrioma recurrence following surgical excision: a systematic review and meta‑analysis.

Authors:  Danni Jiang; Xuxing Zhang; Jiaqi Shi; Dongmei Tao; Xiaocui Nie
Journal:  Arch Gynecol Obstet       Date:  2021-06-20       Impact factor: 2.344

Review 3.  Pathogenesis Based Diagnosis and Treatment of Endometriosis.

Authors:  Philippe R Koninckx; Rodrigo Fernandes; Anastasia Ussia; Larissa Schindler; Arnaud Wattiez; Shaima Al-Suwaidi; Bedayah Amro; Basma Al-Maamari; Zeinab Hakim; Muna Tahlak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-25       Impact factor: 5.555

4.  Molecular Signatures Correlated With Poor IVF Outcomes: Insights From the mRNA and lncRNA Expression of Endometriotic Granulosa Cells.

Authors:  Libing Shi; Xianjiang Wei; Bingbing Wu; Chunhui Yuan; Chao Li; Yongdong Dai; Jianmin Chen; Feng Zhou; Xiang Lin; Songying Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

5.  Does current ovarian endometrioma increase the time for DOR patients to reach live birth in IVF?

Authors:  Yu Deng; Zhanhui Ou; Minna Yin; Zhiheng Chen; Shiling Chen; Ling Sun
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-15       Impact factor: 3.105

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.